エピジェネティクス医薬品・診断技術の世界市場（～2026年）

• 英文タイトル：Global Epigenetics Drugs & Diagnostic Technologies Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11871 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はエピジェネティクス医薬品・診断技術のグローバル市場について調査・分析したレポートです。種類別（エピジェネティクス医薬品、エピジェネティクス診断技術）市場規模、用途別（病院、研究機関、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エピジェネティクス医薬品・診断技術の競争状況、市場シェア ・世界のエピジェネティクス医薬品・診断技術市場：種類別市場規模 2015年-2020年（エピジェネティクス医薬品、エピジェネティクス診断技術） ・世界のエピジェネティクス医薬品・診断技術市場：種類別市場規模予測 2021年-2026年（エピジェネティクス医薬品、エピジェネティクス診断技術） ・世界のエピジェネティクス医薬品・診断技術市場：用途別市場規模 2015年-2020年（病院、研究機関、その他） ・世界のエピジェネティクス医薬品・診断技術市場：用途別市場規模予測 2021年-2026年（病院、研究機関、その他） ・北米のエピジェネティクス医薬品・診断技術市場分析：米国、カナダ ・ヨーロッパのエピジェネティクス医薬品・診断技術市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエピジェネティクス医薬品・診断技術市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエピジェネティクス医薬品・診断技術市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエピジェネティクス医薬品・診断技術市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：4SC、Acetylon Pharmaceuticals、Astex Pharmaceuticals、CellCentric、Celleron Therapeutics、Celgene Corporation、Chroma Therapeutics、Epigentek Group、Eisai、EnVivo Pharmaceuticals、Base Genomics、Oryzon Genomics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Epigenetics Drugs & Diagnostic Technologies Market
The global Epigenetics Drugs & Diagnostic Technologies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epigenetics Drugs & Diagnostic Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epigenetics Drugs & Diagnostic Technologies market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epigenetics Drugs & Diagnostic Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epigenetics Drugs & Diagnostic Technologies market.

Global Epigenetics Drugs & Diagnostic Technologies Scope and Market Size
Epigenetics Drugs & Diagnostic Technologies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Epigenetics Drugs & Diagnostic Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Epigenetics Drugs
Epigenetics Diagnostic Technologies

Market segment by Application, split into
Hospital
Research Institution
Others

Based on regional and country-level analysis, the Epigenetics Drugs & Diagnostic Technologies market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Epigenetics Drugs & Diagnostic Technologies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
4SC
Acetylon Pharmaceuticals
Astex Pharmaceuticals
CellCentric
Celleron Therapeutics
Celgene Corporation
Chroma Therapeutics
Epigentek Group
Eisai
EnVivo Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Epigenetics Drugs
1.2.3 Epigenetics Diagnostic Technologies
1.3 Market by Application
1.3.1 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Research Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Epigenetics Drugs & Diagnostic Technologies Market Perspective (2015-2026)
2.2 Global Epigenetics Drugs & Diagnostic Technologies Growth Trends by Regions
2.2.1 Epigenetics Drugs & Diagnostic Technologies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Epigenetics Drugs & Diagnostic Technologies Historic Market Share by Regions (2015-2020)
2.2.3 Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Market Size
3.1.1 Global Top Epigenetics Drugs & Diagnostic Technologies Players by Revenue (2015-2020)
3.1.2 Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Players (2015-2020)
3.2 Global Epigenetics Drugs & Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epigenetics Drugs & Diagnostic Technologies Revenue
3.4 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Epigenetics Drugs & Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenetics Drugs & Diagnostic Technologies Revenue in 2019
3.5 Key Players Epigenetics Drugs & Diagnostic Technologies Area Served
3.6 Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Epigenetics Drugs & Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Type (2015-2026)
4.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Type (2015-2020)
4.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Type (2021-2026)

5 Epigenetics Drugs & Diagnostic Technologies Breakdown Data by Application (2015-2026)
5.1 Global Epigenetics Drugs & Diagnostic Technologies Historic Market Size by Application (2015-2020)
5.2 Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Epigenetics Drugs & Diagnostic Technologies Market Size (2015-2026)
6.2 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020)
6.3 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020)
6.4 North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Epigenetics Drugs & Diagnostic Technologies Market Size (2015-2026)
7.2 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020)
7.3 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020)
7.4 Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Epigenetics Drugs & Diagnostic Technologies Market Size (2015-2026)
8.2 China Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020)
8.3 China Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020)
8.4 China Epigenetics Drugs & Diagnostic Technologies Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Epigenetics Drugs & Diagnostic Technologies Market Size (2015-2026)
9.2 Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020)
9.3 Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020)
9.4 Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size (2015-2026)
10.2 Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020)
10.3 Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020)
10.4 Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 4SC
11.1.1 4SC Company Details
11.1.2 4SC Business Overview
11.1.3 4SC Epigenetics Drugs & Diagnostic Technologies Introduction
11.1.4 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020))
11.1.5 4SC Recent Development
11.2 Acetylon Pharmaceuticals
11.2.1 Acetylon Pharmaceuticals Company Details
11.2.2 Acetylon Pharmaceuticals Business Overview
11.2.3 Acetylon Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.2.4 Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.2.5 Acetylon Pharmaceuticals Recent Development
11.3 Astex Pharmaceuticals
11.3.1 Astex Pharmaceuticals Company Details
11.3.2 Astex Pharmaceuticals Business Overview
11.3.3 Astex Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.3.4 Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.3.5 Astex Pharmaceuticals Recent Development
11.4 CellCentric
11.4.1 CellCentric Company Details
11.4.2 CellCentric Business Overview
11.4.3 CellCentric Epigenetics Drugs & Diagnostic Technologies Introduction
11.4.4 CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.4.5 CellCentric Recent Development
11.5 Celleron Therapeutics
11.5.1 Celleron Therapeutics Company Details
11.5.2 Celleron Therapeutics Business Overview
11.5.3 Celleron Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.5.4 Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.5.5 Celleron Therapeutics Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Epigenetics Drugs & Diagnostic Technologies Introduction
11.6.4 Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.6.5 Celgene Corporation Recent Development
11.7 Chroma Therapeutics
11.7.1 Chroma Therapeutics Company Details
11.7.2 Chroma Therapeutics Business Overview
11.7.3 Chroma Therapeutics Epigenetics Drugs & Diagnostic Technologies Introduction
11.7.4 Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.7.5 Chroma Therapeutics Recent Development
11.8 Epigentek Group
11.8.1 Epigentek Group Company Details
11.8.2 Epigentek Group Business Overview
11.8.3 Epigentek Group Epigenetics Drugs & Diagnostic Technologies Introduction
11.8.4 Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.8.5 Epigentek Group Recent Development
11.9 Eisai
11.9.1 Eisai Company Details
11.9.2 Eisai Business Overview
11.9.3 Eisai Epigenetics Drugs & Diagnostic Technologies Introduction
11.9.4 Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.9.5 Eisai Recent Development
11.10 EnVivo Pharmaceuticals
11.10.1 EnVivo Pharmaceuticals Company Details
11.10.2 EnVivo Pharmaceuticals Business Overview
11.10.3 EnVivo Pharmaceuticals Epigenetics Drugs & Diagnostic Technologies Introduction
11.10.4 EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
11.10.5 EnVivo Pharmaceuticals Recent Development
11.11 Base Genomics
10.11.1 Base Genomics Company Details
10.11.2 Base Genomics Business Overview
10.11.3 Base Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
10.11.4 Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
10.11.5 Base Genomics Recent Development
11.12 Oryzon Genomics
10.12.1 Oryzon Genomics Company Details
10.12.2 Oryzon Genomics Business Overview
10.12.3 Oryzon Genomics Epigenetics Drugs & Diagnostic Technologies Introduction
10.12.4 Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
10.12.5 Oryzon Genomics Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Epigenetics Drugs
Table 4. Key Players of Epigenetics Diagnostic Technologies
Table 5. Global Epigenetics Drugs & Diagnostic Technologies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2015-2020)
Table 9. Global Epigenetics Drugs & Diagnostic Technologies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2021-2026)
Table 11. Epigenetics Drugs & Diagnostic Technologies Market Market Trends
Table 12. Epigenetics Drugs & Diagnostic Technologies Market Drivers
Table 13. Epigenetics Drugs & Diagnostic Technologies Market Challenges
Table 14. Epigenetics Drugs & Diagnostic Technologies Market Restraints
Table 15. Global Epigenetics Drugs & Diagnostic Technologies Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players (2015-2020)
Table 17. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2019)
Table 18. Global Epigenetics Drugs & Diagnostic Technologies by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Epigenetics Drugs & Diagnostic Technologies Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Epigenetics Drugs & Diagnostic Technologies Market Size Share by Type (2015-2020)
Table 24. Global Epigenetics Drugs & Diagnostic Technologies Revenue Market Share by Type (2021-2026)
Table 25. Global Epigenetics Drugs & Diagnostic Technologies Market Size Share by Application (2015-2020)
Table 26. Global Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Epigenetics Drugs & Diagnostic Technologies Market Size Share by Application (2021-2026)
Table 28. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2015-2020)
Table 30. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2015-2020)
Table 32. North America Epigenetics Drugs & Diagnostic Technologies Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2015-2020)
Table 34. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2015-2020)
Table 36. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2015-2020)
Table 38. Europe Epigenetics Drugs & Diagnostic Technologies Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2015-2020)
Table 40. China Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 41. China Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2015-2020)
Table 42. China Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 43. China Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2015-2020)
Table 44. China Epigenetics Drugs & Diagnostic Technologies Market Size by Region (US$ Million) (2015-2020)
Table 45. China Epigenetics Drugs & Diagnostic Technologies Market Share by Region (2015-2020)
Table 46. Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2015-2020)
Table 48. Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2015-2020)
Table 50. Japan Epigenetics Drugs & Diagnostic Technologies Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2015-2020)
Table 52. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Share by Type (2015-2020)
Table 54. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Share by Application (2015-2020)
Table 56. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Share by Country (2015-2020)
Table 58. 4SC Company Details
Table 59. 4SC Business Overview
Table 60. 4SC Product
Table 61. 4SC Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 62. 4SC Recent Development
Table 63. Acetylon Pharmaceuticals Company Details
Table 64. Acetylon Pharmaceuticals Business Overview
Table 65. Acetylon Pharmaceuticals Product
Table 66. Acetylon Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 67. Acetylon Pharmaceuticals Recent Development
Table 68. Astex Pharmaceuticals Company Details
Table 69. Astex Pharmaceuticals Business Overview
Table 70. Astex Pharmaceuticals Product
Table 71. Astex Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 72. Astex Pharmaceuticals Recent Development
Table 73. CellCentric Company Details
Table 74. CellCentric Business Overview
Table 75. CellCentric Product
Table 76. CellCentric Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 77. CellCentric Recent Development
Table 78. Celleron Therapeutics Company Details
Table 79. Celleron Therapeutics Business Overview
Table 80. Celleron Therapeutics Product
Table 81. Celleron Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 82. Celleron Therapeutics Recent Development
Table 83. Celgene Corporation Company Details
Table 84. Celgene Corporation Business Overview
Table 85. Celgene Corporation Product
Table 86. Celgene Corporation Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 87. Celgene Corporation Recent Development
Table 88. Chroma Therapeutics Company Details
Table 89. Chroma Therapeutics Business Overview
Table 90. Chroma Therapeutics Product
Table 91. Chroma Therapeutics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 92. Chroma Therapeutics Recent Development
Table 93. Epigentek Group Business Overview
Table 94. Epigentek Group Product
Table 95. Epigentek Group Company Details
Table 96. Epigentek Group Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 97. Epigentek Group Recent Development
Table 98. Eisai Company Details
Table 99. Eisai Business Overview
Table 100. Eisai Product
Table 101. Eisai Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 102. Eisai Recent Development
Table 103. EnVivo Pharmaceuticals Company Details
Table 104. EnVivo Pharmaceuticals Business Overview
Table 105. EnVivo Pharmaceuticals Product
Table 106. EnVivo Pharmaceuticals Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 107. EnVivo Pharmaceuticals Recent Development
Table 108. Base Genomics Company Details
Table 109. Base Genomics Business Overview
Table 110. Base Genomics Product
Table 111. Base Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 112. Base Genomics Recent Development
Table 113. Oryzon Genomics Company Details
Table 114. Oryzon Genomics Business Overview
Table 115. Oryzon Genomics Product
Table 116. Oryzon Genomics Revenue in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020) (US$ Million)
Table 117. Oryzon Genomics Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Type: 2020 VS 2026
Figure 2. Epigenetics Drugs Features
Figure 3. Epigenetics Diagnostic Technologies Features
Figure 4. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Research Institution Case Studies
Figure 7. Others Case Studies
Figure 8. Epigenetics Drugs & Diagnostic Technologies Report Years Considered
Figure 9. Global Epigenetics Drugs & Diagnostic Technologies Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions: 2020 VS 2026
Figure 11. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Regions (2021-2026)
Figure 12. Global Epigenetics Drugs & Diagnostic Technologies Market Share by Players in 2019
Figure 13. Global Top Epigenetics Drugs & Diagnostic Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenetics Drugs & Diagnostic Technologies as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Epigenetics Drugs & Diagnostic Technologies Revenue in 2019
Figure 15. North America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Epigenetics Drugs & Diagnostic Technologies Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. 4SC Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 43. Acetylon Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 44. Astex Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 45. CellCentric Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 46. Celleron Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 47. Celgene Corporation Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 48. Chroma Therapeutics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 49. Epigentek Group Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 50. Eisai Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 51. EnVivo Pharmaceuticals Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 52. Base Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 53. Oryzon Genomics Revenue Growth Rate in Epigenetics Drugs & Diagnostic Technologies Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

---